英语资讯
News

疫苗厂商或发"安全宣言"

Source: 恒星英语学习网    2020-09-09  我要投稿   论坛   Favorite  

Vaccine makers plan public stance
疫苗厂商或发“安全宣言”

Drugmakers are planning a public pledge to not send any COVID-19 vaccine to the US Food and Drug Administration for review without extensive safety and efficacy data, according to people familiar with the effort. The joint stance is seen as a bulwark against political pressure being applied on the FDA to get a vaccine out as soon as possible.
知情人士称,多家制药公司正计划发表公开联合承诺,如果没有得到广泛的安全性和有效性测试数据,不会将任何新冠疫苗送交美国食品和药品管理局(FDA)审批。

The companies involved in the discussions include Pfizer Inc, Moderna Inc, Johnson and Johnson, GlaxoSmithKline Plc, Sanofi, and possibly others. All are developing vaccines for COVID-19.
FDA正面临尽快批准疫苗的政治压力,这些制药公司的联合立场是对这种情况的防备。参与讨论的公司包括辉瑞、莫德纳、强生,葛兰素史克、赛诺菲等,这些药企都在研发新冠疫苗。

The drug industry has long relied on the FDA as a gold-standard approver for its drugs. But in the middle of the pandemic, the agency has made several controversial decisions to allow emergency use of therapies without rock-solid evidence they work.
制药业向来以FDA的审批作为药品的黄金标准,但在此次疫情期间,FDA做出了几次有争议的决定,在没有确定疗效前就允许紧急使用一些新冠疗法。

One recent poll found a majority of the US public thought a vaccine approval would be driven by politics.
最近一项民调显示,多数受访美国民众认为,新冠疫苗的审批将会被政治化。

US President Donald Trump has accused the FDA of slowing work to hurt him politically, and said he believes a vaccine will be ready before Election Day on Nov 3.
美国总统特朗普指责FDA故意拖延疫苗工作,目的是在政治上给他造成伤害,他还表示,新冠疫苗能够在11月3日大选前准备好。


将本页收藏到:
上一篇:我国发射"可复用航天器"
下一篇:印尼防疫出狠招 不戴口罩被罚躺棺材

最新更新
论坛精彩内容
网站地图 - 学习交流 - 恒星英语论坛 - 关于我们 - 广告服务 - 帮助中心 - 联系我们
Copyright ©2006-2007 www.Hxen.com All Rights Reserved